Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.
Nguyen O, Wiedrick J, Massera D, Adlestein E, Frejat S, Castrichini M, Alsidawi S, Giudicessi JR, Geske JB, Carrick RT, Madrazo J, Dellise N, Zenker MA, Boyle TA, Reza N, Owens AT, Frankel DS, Hundal P, Tajik J, Galazka P, Lewontin M, Ayers M, Wong T, Flanagan M, Mitter SS, Kanwal A, Bilen O, Baghdadi S, Shah H, Kvapil J, Roldan P, Berenbom L, Jesurum J, Tootill D, Siqueira-Benzow A, Harper M, Saleh D, Choudhury L, Valenta I, Lang M, Phelan DM, Prizand D, Lakdawala N, Ho CY, Liang LW, Weiner SD, Ravi S, Abuzaid AS, Makkiya M, Markowitz JS, Sherrid M, Masri A.
Nguyen O, et al. Among authors: makkiya m.
medRxiv [Preprint]. 2025 Sep 19:2025.09.15.25335783. doi: 10.1101/2025.09.15.25335783.
medRxiv. 2025.
PMID: 41001473
Free PMC article.
Preprint.